Kymera Therapeutics KYMR
NASDAQ KYMR
$107.39 -2.73 (-2.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kymera Therapeutics (KYMR) Asset Writedowns and Impairment (2024 - 2025)

Updated

Kymera Therapeutics (KYMR) reported Asset Writedowns and Impairment of $45,000 for Q4 2025, down 98.8% from the prior quarter.

Analysis

Kymera Therapeutics (KYMR) Asset Writedowns and Impairment (2024 - 2025) Analysis & Trends

For FY2025, Kymera Therapeutics posted Asset Writedowns and Impairment of $3.9 million, down 20.8% from FY2024.

  • By year, Asset Writedowns and Impairment came in at $4.93 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Kymera Therapeutics 8.89 Bn 6.19 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 45,000.00
Sep 30, 2025 3.86 Mn
Mar 31, 2024 4.93 Mn
API Access

Kymera Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=KYMR&period=max&api_key=YOUR_API_KEY